Exercise-based rehabilitation programmes for pulmonary hypertension

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 10, 2014, Pages

  Morris, Norman R ^a   Kermeen, Fiona D ^b   Holland, Anne E ^c,d,e  

^a GRIFFITH UNIVERSITY   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

^d Alfred Health   (Australia)

^e AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBIC EXERCISE; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; EXERCISE; EXERCISE INTENSITY; HUMAN; INCIDENCE; OUTCOME ASSESSMENT; PATIENT SAFETY; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY REHABILITATION; RESISTANCE TRAINING; STATISTICAL BIAS; SYSTEMATIC REVIEW; THERAPY EFFECT; TRAINING;

EID: 84942330905     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD011285     Document Type: Article

References (30)

1. Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, et al.Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation 2010;122(2):164-72.
2. Casserly B, Klinger JR. Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent. Drug Design, Development and Therapy 2009;3:269-87.
3. Coggan AR, Spina RJ, King DS, Rogers MA, Brown M, Nemeth PM, et al.Skeletal muscle adaptations to endurance training in 60- to 70-yr-old men and women. Journal of Applied Physiology 1992;72(5):1780-6.
4. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al.Survival in patients with primary pulmonary hypertension: Results from a national prospective registry. Annals of Internal Medicine 1991;115(5):343-9.
5. de Man FS, Handoko ML, Groepenhoff H, van't Hul AJ, Abbink J, Koppers RJ, et al.Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. European Respiratory Journal 2009;34(3):669-75.
6. Ennion S, Sant'ana Pereira J, Sargeant AJ, Young A, Goldspink G. Characterization of human skeletal muscle fibres according to the myosin heavy chains they express. Journal of Muscle Research and Cell Motility 1995;16(1):35-43.
7. Fowler RM, Gain KR, Gabbay E. Exercise intolerance in pulmonary arterial hypertension. Pulmonary Medicine 2012;2012(Article ID 359204):10 pages. [DOI: 10.1155/2012/359204]
8. Frost AE, Badesch DB, Miller DP, Benza RL, Meltzer LA, McGoon MD. Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysis. Chest 2013;144(5):1521-9.
9. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al.Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal 2009;34(6):1219-63.
10. Galie N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, et al.Updated treatment algorithm of pulmonary arterial hypertension. Journal of the American College of Cardiology 2013;62(25 Suppl):D60-72.
11. Gollnick PD, Armstrong RB, Saltin B, Saubert CW, Sembrowich WL, Shepherd RE. Effect of training on enzyme activity and fiber composition of human skeletal muscle. Journal of Applied Physiology 1973;34(1):107-11.
12. Jan Brozek, Andrew Oxman, Holger Schünemann. GRADEpro. 3.2 for Windows. Jan Brozek, Andrew Oxman, Holger Schünemann, 2008.
13. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
14. Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, et al.Definitions and diagnosis of pulmonary hypertension. Journal of the American College of Cardiology 2013;62(25 Suppl):D42-50.
15. Mainguy V, Maltais F, Saey D, Gagnon P, Martel S, Simon M, et al.Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax 2010;65(2):113-7.
16. Mainguy V, Maltais F, Saey D, Gagnon P, Martel S, Simon M, et al.Effects of a rehabilitation program on skeletal muscle function in idiopathic pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation 2010;30(5):319-23.
17. McGoon MD, Benza RL, Escribano-Subias P, Jiang X, Miller DP, Peacock AJ, et al.Pulmonary arterial hypertension: epidemiology and registries. Journal of the American College of Cardiology 2013;62(25 Suppl):D51-9.
18. Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9. Boston, Mass: Little, Brown & Co, 1994:253-255.
19. Ogawa T, Spina RJ, Martin WH 3rd, Kohrt WM, Schechtman KB, Holloszy JO, et al.Effects of aging, sex, and physical training on cardiovascular responses to exercise. Circulation 1992;86(2):494-503.
20. Pluim BM, Zwinderman AH, van der Laarse A, van der Wall EE. The athlete's heart. A meta-analysis of cardiac structure and function. Circulation 2000;101(3):336-44.
21. Provencher S, Chemla D, Herve P, Sitbon O, Humbert M, Simonneau G. Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension. European Respiratory Journal 2006;27(1):114-20.
22. Provencher S, Herve P, Sitbon O, Humbert M, Simonneau G, Chemla D. Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension. European Respiratory Journal 2008;32(2):393-8.
23. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
24. Riley MS, Porszasz J, Engelen MP, Shapiro SM, Brundage BH, Wasserman K. Responses to constant work rate bicycle ergometry exercise in primary pulmonary hypertension: the effect of inhaled nitric oxide. Journal of the American College of Cardiology 2000;36(2):547-56.
25. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al.Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology 2013;62(25 Suppl):D34-41.
26. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al.An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine 2013;188(8):e13-64.
27. Strange G, Playford D, Stewart S, Deague JA, Nelson H, Kent A, et al.Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart 2012;98(24):1805-11.
28. Tuder RM, Archer SL, Dorfmüller P, Erzurum SC, Guignabert C, Michelakis E, et al.Relevant issues in the pathology and pathobiology of pulmonary hypertension. Journal of the American College of Cardiology 2013;62(25 Suppl):D4-12.
29. Vogiatzis I, Zakynthinos S. The physiological basis of rehabilitation in chronic heart and lung disease. Journal of Applied Physiology 2013;115(1):16-21.
30. Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S, et al.Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Medicine and Science in Sports and Exercise 1998;30(10):1467-74.